original ) (raw )Trade Rules and Intellectual Property Protection for Pharmaceuticals
Valbona Muzaka
View PDFchevron_right
Implications of bilateral free trade agreements on access to medicines
Carlos Correa
Bulletin of The World Health Organization, 2006
View PDFchevron_right
The Inadequate Global Policy Response to Trade-Related Intellectual Property Rights: Impact on Access to Medicines in Low- and Middle-Income Countries
Lisa Forman
Maryland Journal of International Law, 2016
View PDFchevron_right
Intellectual Property Rights In Bilateral Investment Treaties and Access to Medicines: the Case of Latin America
Rosa Castro
The Journal of World Intellectual Property, 2006
View PDFchevron_right
Lisa Forman, “Trading Health for Profit: Bilateral and Regional Free Trade Agreements Affecting Domestic Property Rules on Pharmaceuticals”
Lisa Forman
Jillian Clare Cohen, Udo Schuklenk and Patricia Illingsworth, eds., The Power of Pills: Social, Ethical and Legal Issues in Drug Development, Marketing, and Pricing (London: Pluto Press, 2006)., 2006
View PDFchevron_right
Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001-2016
Brigit Toebes
Bulletin of the World Health Organization, 2018
View PDFchevron_right
The TAFTA, TTIP, and Treatment Access: What Does the Agreement Mean for Intellectual Property Rights Over Essential Medicines?
Faisal Chaudhry
The Transatlantic Colossus,: lobal Contributions To Broaden The Debate On The EU-US Free Trade Agreement, eds. David Cardoso, et al.., 2014
View PDFchevron_right
Rights" and Wrongs: What Utility for the Right to Health in Reforming Trade Rules on Medicines?
Lisa Forman
Health and Human Rights, 2008
View PDFchevron_right
TRIPS-Plus Free Trade Agreements and Access to Medicines
Susan Sell
Liverpool Law Review, 2007
View PDFchevron_right
Access to Medicines 2.0: Preferential Trade Agreements as an Impediment to Access
Holger Hestermeyer
View PDFchevron_right
A Trade Agreement's Impact On Access To Generic Drugs
Ellen Shaffer
Health Affairs, 2009
View PDFchevron_right
Common Health Policy Interests and the Shaping of Global Pharmaceutical Policies
Meri Koivusalo
Ethics & International Affairs, 2010
View PDFchevron_right
Policy & practice Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001–2016
Brigit Toebes
View PDFchevron_right
The Trans Pacific Partnership Agreement, intellectual property and medicines: Differential outcomes for developed and developing countries
Ruth Lopert
Global social policy, 2018
View PDFchevron_right
Patents, trade and medicines: past, present and future
Amy Kapczynski
Review of International Political Economy, 2019
View PDFchevron_right
Global Issues and Business in International Relations: Intellectual Property Rights and Access to Medicines
Yoshiko KOJO
International Relations of the Asia-Pacific, 2018
View PDFchevron_right
Lisa Forman, "Human Rights Impact Assessment Of Trade-Related Intellectual Property Rights: A Key Strategy In Post-2015 Efforts To Improve Access To Safe And Accessible Medicines" (2013)
Lisa Forman
(2013) 1:1 Journal of Health Diplomacy
View PDFchevron_right
Effects of TRIPSPlus Provisions in International Trade Agreements upon Access to Medicines in Developing Countries
Sandeep Mittal
Journal of Intellectual Property Rights (JIPR) : [776] ISSN: 0975-1076 (Online); 0971-7544 (Print) JIPR Vol.22(6) [November 2017] Page(s): 295-302, 2017
View PDFchevron_right
The Wto Deal on Cheap Drugs: A Critique
GopaKumar K M
The Journal of World Intellectual Property, 2005
View PDFchevron_right
The High Price of “Free” Trade: U.S. Trade Agreements and Access to Medicines
Ruth Lopert
View PDFchevron_right
TRIPS to Where? A Narrative Review of the Empirical Literature on Intellectual Property Licensing Models to Promote Global Diffusion of Essential Medicines
HILDE STEVENS
Pharmaceutics, 2021
View PDFchevron_right
What is the impact of intellectual property rules on access to medicines? A systematic review
Brigitte Tenni
Globalization and Health
View PDFchevron_right
Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere
brook baker
PLOS Medicine
View PDFchevron_right
Pharmaceutical industry behaviour and the Trans Pacific Partnership Agreement
Erik Monasterio
The New Zealand medical journal, 2014
View PDFchevron_right
Effects Of The Trade Related Aspects of Intellectual Property (TRIPS) On Access to Pharmaceuticals in Developing Countries
Birute Aleknaite
View PDFchevron_right
Impacts of intellectual property provisions in trade treaties on access to medicine in low and middle income countries: a systematic review
Warren Kaplan
Globalization and Health
View PDFchevron_right
The WTO’s Compulsory Licencing of Patented Pharmaceuticals: Implementation Challenges
Milorad Stamenovic
Međunarodna politika 75(1190):39-55, 2024
View PDFchevron_right
CROSS-SECTIONAL ANALYSIS OF THE COUNTRIES AND CORRESPONDING TRIPS FLEXIBILITIES FOR PHARMACEUTICALS
Milorad Stamenovic
Auditor, 2023
View PDFchevron_right
Trade Rules, Intellectual Property, and the Right to Health
Lisa Forman
Ethics & International Affairs, 2007
View PDFchevron_right
Excessive prices and access to medicines – Compulsory licensing as an anticompetitive remedy under the TRIPS Agreement
Behrang Kianzad
2019
View PDFchevron_right
ii Seuba — Free Trade of Pharmaceutical Products: The Limits of Intellectual Property Enforcement at the Border Published by
sophie bloemen
2010
View PDFchevron_right
Patents for Drugs and the Right to Development in International Law
Olasupo Owoeye
Law and Development Review, 2015
View PDFchevron_right
Assessing the impact of the Australia-United States Free Trade Agreement on Australian and global medicines policy
Evan Doran
Globalization and Health, 2005
View PDFchevron_right
Developing Countries and Intellectual Property Enforcement Measures: Improving Access to Medicines through WTO Dispute Settlement
Melissa Blue Sky
View PDFchevron_right
Doha Declaration and access to drugs and medicines
Anjali Mohandas
View PDFchevron_right